Steve Cutler is Chief Operating Officer of ICON, and will assume the role of Chief Executive Officer on 1st March, 2017. Dr. Cutler is also a member of ICON’s Board of Directors. Dr. Cutler joined ICON in 2011 and is responsible for leading the company’s global operations, strategic customer alliances and the management of more than 460 clinical development projects from Phase IIb – IV. Steve has over 28 years of pharma and CRO experience. Prior to ICON, he was Chief Executive Officer of Kendle and oversaw the sale of the company to INC Research. Prior to Kendle, Dr. Cutler held various operational and general management roles in both Quintiles and Sandoz (Novartis).